P. Oehr

Most-cited papers

1. Imaging of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine and SPECT

   H. Biersack, H. Coenen, G. Stocklin, K. Reichmann +4 more

   1989119 citations

   Semantic Scholar

   Save

2. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.

   K. Bouchelouche, P. Oehr

   2008Journal of Urology110 citations

   Semantic Scholar

   Save

3. Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.

   P. Kenemans, G. V. van Kamp, P. Oehr, R. Verstraeten

   1993Clinical Chemistry72 citations

   Semantic Scholar

   Save

4. Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice

   Juergen Ruhlmann, A. Schomburg, H. Bender, P. Oehr +5 more

   1997Diseases of the Colon & Rectum64 citations

   Semantic Scholar

   Save

5. Recent developments in urologic oncology: positron emission tomography molecular imaging

   K. Bouchelouche, P. Oehr

   2008Current Opinion in Oncology49 citations

   Semantic Scholar

   Save

6. Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection.

   Jochen Reinsberg, A. Heydweiller, U. Wagner, K. Pfeil +2 more

   1990Clinical Chemistry39 citations Open access

   Semantic Scholar

   Save

7. PET in Oncology

   J. Ruhlmann, P. Oehr, H. Biersack

   1999Springer Berlin Heidelberg33 citations

   Semantic Scholar

   Save

8. Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT.

   H. Biersack, H. Coenen, G. Stocklin, K. Reichmann +4 more

   1989Journal of Nuclear Medicine33 citations

   Semantic Scholar

   Save

9. Clinical PET in oncology.

   H. Biersack, H. Bender, J. Ruhlmann, P. Oehr +2 more

   2000Revista Española de Medicina Nuclear32 citations

   Semantic Scholar

   Save

10. Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer

    K. Bouchelouche, J. Capala, P. Oehr

    2009Current Opinion in Oncology30 citations Open access

    Semantic Scholar

    Save

11. [Clinical use of photodynamic therapy in gynecologic tumor patients--antibody-targeted photodynamic laser therapy as a new oncologic treatment procedure].

    S. Schmidt, U. Wagner, P. Oehr, D. Krebs

    1992Zentralblatt für Gynäkologie29 citations

    Semantic Scholar

    Save

12. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.

    U. Wagner, P. Oehr, J. Reinsberg, S. Schmidt +5 more

    1992Biotechnology therapeutics27 citations

    Semantic Scholar

    Save

13. Proteomics as a tool for detection of nuclear matrix proteins and new biomarkers for screening of early tumors stage.

    P. Oehr

    2003Anticancer Research23 citations

    Semantic Scholar

    Save

14. Imaging of prostate cancer

    P. Oehr, K. Bouchelouche

    2007Current Opinion in Oncology22 citations

    Semantic Scholar

    Save

15. Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis.

    Uwe Reinhold, G. Pawelec, W. Wehrmann, S. Kukel +2 more

    1989Acta Dermato-Venereologica21 citations

    Semantic Scholar

    Save

16. Streptavidin and biotin as potential tumor imaging agents.

    P. Oehr, J. Westermann, H. Biersack

    1988Journal of Nuclear Medicine21 citations

    Semantic Scholar

    Save

17. The role of nuclear medicine in oncology

    H. Biersack, B. Briele, A. Hotze, P. Oehr +3 more

    1992Annals of Nuclear Medicine19 citations

    Semantic Scholar

    Save

18. Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer

    H. Adolphs, P. Oehr

    2004Urological research14 citations

    Semantic Scholar

    Save

19. PET in oncology : basics and clinical application

    J. Ruhlmann, P. Oehr, H. Biersack

    199913 citations

    Semantic Scholar

    Save

20. Metabolism and Transport of Glucose and FDG

    P. Oehr

    199912 citations

    Semantic Scholar

    Save

21. Fdg-pet in clinical oncology: review and evaluation of results of a private clinical pet center

    J. Ruhlmann, P. Oehr, C. Menzel, K. Kley +3 more

    199812 citations

    Semantic Scholar

    Save

22. [Photodynamic laser therapy with antibody-bound dyes. A new procedure in therapy of gynecologic malignancies].

    Stephan Schmidt, U. Wagner, B. Schultes, P. Oehr +5 more

    1992Fortschritte der Medizin12 citations

    Semantic Scholar

    Save

23. Serum TPS versus TPA in Egyptian Bladder Cancer Patients

    A. Halim, O. El-ahmady, S. Hamza, M. Aboul-Ela +1 more

    1993International Journal of Biological Markers9 citations

    Semantic Scholar

    Save

24. Tumour imaging with labelled liposomes.

    B. Briele, A. Hotze, P. Oehr, H. Biersack +4 more

    1990The Lancet9 citations

    Semantic Scholar

    Save

25. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.

    J. Vogel, P. Oehr, R. Maisey, H. Adolphs

    1988Cancer Detection and Prevention9 citations

    Semantic Scholar

    Save

26. 'Omics'-based imaging in cancer detection and therapy.

    P. Oehr

    2006Personalized Medicine8 citations

    Semantic Scholar

    Save

27. Carrier systems in PDT: on the way to novel antitumor drugs

    J. Moser, Anja Ruebner-Heuermann, P. Oehr, H. Scheer +2 more

    1995Other Conferences8 citations

    Semantic Scholar

    Save

28. Clinical Results of Immunoscintigraphy in a Variety of Malignant Tumors with Special Reference to Immunohistochemistry

    H. Biersack, A. Bockisch, P. Oehr, A. Knoblich +8 more

    1986Nuklearmedizin8 citations

    Semantic Scholar

    Save

29. Photodynamic laser therapy of carcinomas — effects of five different photosensitizers in the colony-forming assay

    Stephan Schmidt, B. Schultes, U. Wagner, P. Oehr +4 more

    2006Archives of Gynecology and Obstetrics7 citations

    Semantic Scholar

    Save

30. Simultaneous Determination of Urinary CEA, Ferritin and TPA in Egyptian Bladder Cancer Patients

    A. Halim, O. El-ahmady, S. Hamza, M. Aboul-Ela +1 more

    1992International Journal of Biological Markers7 citations

    Semantic Scholar

    Save

31. Establishment and Characterization of an Empirical Biomarker SS/PV-ROC Plot Using Results of the UBC® Rapid Test in Bladder Cancer

    P. Oehr, T. Ecke

    2020Entropy6 citations Open access

    Semantic Scholar

    Save

32. [Determination of the optimal L-thyroxine dosage for treating nontoxic goiter].

    H. Biersack, W. Albrecht, P. Oehr, A. Rasche +1 more

    2008Deutsche Medizinische Wochenschrift6 citations

    Semantic Scholar

    Save

33. PET in der Onkologie

    J. Ruhlmann, P. Oehr, H. Biersack

    19986 citations

    Semantic Scholar

    Save

34. [Scintigraphic detection of malignancies with radioactively labelled tumor antibodies. Clinical results based on immunohistochemical research].

    H. Biersack, A. Bockisch, J. Vogel, P. Oehr +5 more

    2008Deutsche Medizinische Wochenschrift5 citations

    Semantic Scholar

    Save

35. Computer modeling of cytokeratin release in clinical oncology.

    P. Oehr, V. Vacata, J. Ruhlmann, H. Rink

    1997Anticancer Research5 citations

    Semantic Scholar

    Save

36. Idiotypic Cascades after Injection of the Monoclonal Antibody OC125: A Study in a Mouse Model. Induction of Antibodies against OC125 and CA 125 after Immunization with an Anti-CA 125 (MAb OC125) Monoclonal Antibody by Activation of the Idiotypic Network

    B. Schultes, Jochen Reinsberg, Harald Schlebusch, P. Oehr +3 more

    1993European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies5 citations Open access

    Semantic Scholar

    Save

37. Tissue Polypeptide Antigen and Specific TPA

    P. Oehr, Manfred L. Lüthgens, Qian Liu

    19925 citations

    Semantic Scholar

    Save

38. Clinical Use of TPA in Cancer of the Urinary Bladder Using CEA for Comparison

    P. Oehr, H. Adolphs, R. Altmann

    19845 citations

    Semantic Scholar

    Save

39. [PET scan in general practice for diagnosis of breast carcinoma].

    J. Ruhlmann, P. Oehr, H. Bender, B. Kozak +3 more

    1997Acta Medica Austriaca4 citations

    Semantic Scholar

    Save

40. Transport and Metabolism of Glucose and FDG

    P. Oehr

    20043 citations

    Semantic Scholar

    Save

41. Prognostic Values of TPA, CEA and their Combination by Product Formation in Different Cancer Locations

    P. Oehr, Christoph Winkler, U. Bönnen

    19853 citations

    Semantic Scholar

    Save

42. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].

    J. Vogel, P. Oehr, V. Grouls

    1985Der Pathologe3 citations

    Semantic Scholar

    Save

43. Clinical Significance of Combined TPA and CEA Determinations During Chemotherapy and/or Radiotherapy in Patients with Breast Cancer or Lung Cancer

    P. Oehr, G. Barzen, R. Schmidt, H. Schwabe +2 more

    19843 citations

    Semantic Scholar

    Save

44. Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis.

    K. Kley, P. Oehr

    2010Anticancer Research2 citations

    Semantic Scholar

    Save

45. The application of immunotargeting into cancer chemotherapy with carboplatin: in vitro and in vivo studies.

    Yoriko Ota, P. Oehr, Noriyuki Inaba, H. Takamizawa

    2010Journal of Obstetrics and Gynaecology Research2 citations

    Semantic Scholar

    Save

46. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer

    J. Brökelmann, A. Bockisch, J. Vogel, Jochen Reinsberg +3 more

    2005Archives of Gynecology and Obstetrics2 citations

    Semantic Scholar

    Save

47. Comparison between cell kinetical and immunohistochemical studies on carcinoma and atypia/dysplasia of urinary bladder mucosa

    B. Helpap, J. Vogel, P. Oehr, H. Adolphs

    2004Virchows Archiv2 citations

    Semantic Scholar

    Save

48. PET in Cell Cultures: Oncology, Genetics, and Therapy

    P. Oehr, N. Gilbert, H. Lemmoch, M. Ludwig +3 more

    20042 citations

    Semantic Scholar

    Save

49. 265: Non-Invasive Screening of Urinary Bladder Cancer - Is NMP22®Bladderchek™ Paving the a Venue?

    P. Oehr

    20042 citations Open access

    Semantic Scholar

    Save

50. THE VALUE OF FDG-PET WHOLE BODY IMAGING, CONVENTIONAL IMAGING, AND SERUM S-100 DETERMINATIONS IN METASTATIC MALIGNANT MELANOMA

    P. Oehr, G. Stegemann, K. Steen, J. Ruhlmann

    19992 citations

    Semantic Scholar

    Save